Vital Signs - 17 July 2006


Regular Price: USD 1,500.00

Special Price USD 1,050.00

30% OFF

* Required Fields

Regular Price: USD 1,500.00

Special Price USD 1,050.00


Be the first to review this product

This issue of Vital Signs, released on July 17, 2006, provides a strategic overview of the practice of product lifecycle management by pharmaceutical companies to identify new pathways that may be able to increase the revenue upside of a product. Additionally, an emerging company profile is provided on Inspire Pharmaceuticals, an innovative pharmaceutical company with a strong scientific background in ophthalmology, respiratory disease and P2 receptor technology. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of July 5 - July 8, 2006.

Table of Contents

Vital Signs - 17 July 2006Product Lifecycle Strategies in the Pharmaceutical IndustryProduct Lifecycle Strategies in the Pharmaceutical Industry

Related Research

Release Date : 21-Nov-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.